Hawley Seeks To Strip FDA Approval Of Mifepristone

Sen. Josh Hawley introduced the Safeguarding Women from Chemical Abortions Act to withdraw FDA approval of mifepristone and bar its use for abortion.

The Justice Department moved to dismiss Missouri v. FDA, asking courts to pause efforts to block mail-order mifepristone while the FDA conducts a safety review.

At a Capitol Hill press conference four women described complications they said followed taking mifepristone, and pro-life groups including the Alliance Defending Freedom spoke at the event.

Hawley cited an Ethics and Public Policy Center review of 865,727 insurance claims from 2017 through 2023 that he said showed roughly 11% serious adverse events, and the Guttmacher Institute said mifepristone accounted for 63% of U.S. abortions in 2023.

Hawley said he will seek 60 Senate votes to overcome a filibuster to advance the bill.